Professeur en thérapeutique, Université de Rennes 1 - Université de Rennes
Hallucinogens approved for treating psychiatric disorders: what does the science say?
Dec 28, 2024 07:16 am UTC| Insights & Views Health
Once sidelined in the 1970s, psychedelic substances ranging from esketamine (a ketamine derivative) and psilocybin (the active ingredient in hallucinogenic mushrooms) to MDMA are being reintroduced as potential therapies...
China's Deflationary Woes: CPI and PPI Signal Persistent Economic Challenges
Trump's Tariff U-Turn: 90-Day Reprieve for Most, China Still in the Crosshairs
Trade War Escalates: China Fires Back with 84% Tariff on US Goods
China's Treasury "Nuclear Option": Bluff or Reality?